ベムラフェニブ (BRAFi) とセツキシマブ (EGFRi) を PD-1 モノクローナル抗体と併用の臨床試験
合計1件
-
West China Hospital募集BRAF V600E変異/MSS 転移性結腸直腸がん | ベムラフェニブ (BRAFi) とセツキシマブ (EGFRi) を PD-1 モノクローナル抗体と併用中国
このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。
スポンサーと協力者
- Forschungsverbund Rehabilitationswissenschaften Sachsen-Anhalt
- Evolve BioSystems, Inc.
- Kolfarma s.r.l. - Italy
- CirQuest Labs
- Alfred Benzon Foundation
- Ramboll Group
- Crovelis
- Dr Jérôme Rambaud, MD, PhD; Sorbonne University, Paris, France
- Penza State University
- University of Houston
- National University Polyclinics, Singapore
- Universal Biosensors Pty Ltd
- MITERA Children's Hospital
- Siddhartha Ganguly
- The University of Texas System Healthcare Safety & Effectiveness Grants Program
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- No.2 People Hospital of Fuyang City
- Midlothian Care Center
- IRCCS-Istituto delle scienze neurologiche di Bologna
- BioSensics LLC
- 全リストを表示
CROs by country
- Contract Research Organizations in Gabon
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mexico
- Contract Research Organizations in Norway
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Peru
- Contract Research Organizations in Philippines
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Uganda
- Contract Research Organizations in United Kingdom
- CRO list by country